![Jin Woo Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jin Woo Kim
Chief Operating Officer at
PRESTIGE BIOPHARMA LIMITED
Net worth: 8 M $ as of 30/06/2026
Profile
Jin Woo Kim is currently the Chief Operating Officer & Director at Prestige BioPharma Ltd. He previously worked as a Director at Prestige Biologics Co., Ltd. and as a Managing Director at Qion Pte Ltd. Mr. Kim holds an MBA from New York University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/07/2026 | 1,807,620 ( 3.01% ) | 8 M $ | 30/06/2026 |
Jin Woo Kim active positions
| Companies | Position | Start |
|---|---|---|
| PRESTIGE BIOPHARMA LIMITED | Chief Operating Officer | - |
Former positions of Jin Woo Kim
| Companies | Position | End |
|---|---|---|
| PRESTIGE BIOLOGICS CO., LTD. | Director/Board Member | - |
Qion Pte Ltd. | Chief Executive Officer | - |
Training of Jin Woo Kim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prestige Biologics Co., Ltd.
 Prestige Biologics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies antibody pharmaceuticals | Health Technology |
Prestige BioPharma Ltd.
 Prestige BioPharma Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biosimilars and antibody therapeutics | Health Technology |
Qion Pte Ltd. |
- Stock Market
- Insiders
- Jin Woo Kim
